Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease
Clinical trial NCT02194985 · COMPLETED
Trial details
- NCT number
- NCT02194985
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-14
- Primary completion
- 2019-10-23
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.